AU694410B2 - Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer - Google Patents

Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer

Info

Publication number
AU694410B2
AU694410B2 AU55632/94A AU5563294A AU694410B2 AU 694410 B2 AU694410 B2 AU 694410B2 AU 55632/94 A AU55632/94 A AU 55632/94A AU 5563294 A AU5563294 A AU 5563294A AU 694410 B2 AU694410 B2 AU 694410B2
Authority
AU
Australia
Prior art keywords
cancer
prevention
system containing
transdermal administration
acetylsalicylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU55632/94A
Other languages
English (en)
Other versions
AU5563294A (en
Inventor
Frank Becher
Thomas Kissel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4241128A external-priority patent/DE4241128C2/de
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Priority claimed from PCT/EP1993/003231 external-priority patent/WO1994013302A1/de
Publication of AU5563294A publication Critical patent/AU5563294A/en
Application granted granted Critical
Publication of AU694410B2 publication Critical patent/AU694410B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU55632/94A 1992-12-07 1993-11-18 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer Ceased AU694410B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4241128A DE4241128C2 (de) 1991-12-20 1992-12-07 Verwendung eines transdermalen Verabreichungssystems, das als Wirkstoff Acetylsalicylsäure und/oder pharmazeutisch akzeptable Salze davon enthält
DE4241128 1992-12-07
PCT/EP1993/003231 WO1994013302A1 (de) 1991-12-20 1993-11-18 Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe

Publications (2)

Publication Number Publication Date
AU5563294A AU5563294A (en) 1994-07-04
AU694410B2 true AU694410B2 (en) 1998-07-23

Family

ID=6474576

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55632/94A Ceased AU694410B2 (en) 1992-12-07 1993-11-18 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer

Country Status (14)

Country Link
EP (1) EP0671916A1 (de)
JP (1) JP3799502B2 (de)
AU (1) AU694410B2 (de)
CA (1) CA2150033A1 (de)
CZ (1) CZ149495A3 (de)
FI (1) FI120719B (de)
HR (1) HRP931474A2 (de)
HU (1) HUT75680A (de)
IL (1) IL107867A (de)
NO (1) NO952234L (de)
NZ (1) NZ258129A (de)
PL (1) PL174770B1 (de)
SK (1) SK75495A3 (de)
ZA (1) ZA939126B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040209907A1 (en) * 2003-01-23 2004-10-21 Richard Franklin Formulation and methods for the treatment of thrombocythemia
AU2004315561B2 (en) 2004-02-16 2010-10-28 Teikoku Seiyaku Co., Ltd. External preparation for treating painful skin wound
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
JP6720257B2 (ja) * 2018-09-05 2020-07-08 テックフィールズ インコーポレイテッド 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0055635A1 (de) * 1980-12-19 1982-07-07 Laboratoires du Docteur P. ASTIER Pharmazeutische Zusammensetzung in Gelform, die Acetylsalicylilsäure enthält
DE3413052A1 (de) * 1983-06-13 1984-12-13 Rafa Labor Ltd Pharmazeutische zubereitung und deren verwendung zur behandlung von hauterkrankungen
AU3158993A (en) * 1991-12-20 1993-07-28 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0055635A1 (de) * 1980-12-19 1982-07-07 Laboratoires du Docteur P. ASTIER Pharmazeutische Zusammensetzung in Gelform, die Acetylsalicylilsäure enthält
DE3413052A1 (de) * 1983-06-13 1984-12-13 Rafa Labor Ltd Pharmazeutische zubereitung und deren verwendung zur behandlung von hauterkrankungen
AU3158993A (en) * 1991-12-20 1993-07-28 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis

Also Published As

Publication number Publication date
FI120719B (fi) 2010-02-15
NO952234D0 (no) 1995-06-06
HUT75680A (en) 1997-05-28
CA2150033A1 (en) 1994-06-23
JP3799502B2 (ja) 2006-07-19
SK75495A3 (en) 1996-05-08
HRP931474A2 (en) 1994-12-31
FI952805A (fi) 1995-06-07
EP0671916A1 (de) 1995-09-20
PL309285A1 (en) 1995-10-02
JPH08504198A (ja) 1996-05-07
NZ258129A (en) 1999-10-28
NO952234L (no) 1995-06-06
AU5563294A (en) 1994-07-04
IL107867A0 (en) 1994-04-12
ZA939126B (en) 1994-08-05
IL107867A (en) 1998-08-16
CZ149495A3 (en) 1996-03-13
PL174770B1 (pl) 1998-09-30
FI952805A0 (fi) 1995-06-07
HU9501641D0 (en) 1995-08-28

Similar Documents

Publication Publication Date Title
AU4778893A (en) System of drug delivery to the lymphatic tissues
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
EP0692975A4 (de) Verabreichung eines vaso-aktiven wirkstoffes und eines therapeutischen wirkstoffes
AU7289694A (en) Three part device for the transdermic administration of drugs by electrophoresis or iontophoresis
AU4370593A (en) Tissue-specific implantable therapeutic agent delivery system
AU2816589A (en) Self-regulated therapeutic agent delivery system and method
HU9303283D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
AU4090093A (en) Medicine containing benzoic acid derivative and novel benzoic acid derivative
AU6587294A (en) Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
AU6226894A (en) Implantable therapy systems and methods
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
AU7549787A (en) Isoliquiritigenin for the treatment of kidney and liver diseases
AU6934691A (en) Transdermal administration of zwitterionic drugs
IL101410A0 (en) Formulation for the treatment of cancer
AU1956092A (en) Pharmaceutical agent for treatment of withdrawal symptoms
AU4633893A (en) Liposomal formulations for administering to cancer patients
AU694410B2 (en) Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer
AU4220193A (en) Deazaaminopterins for treatment of inflammation
HU9402816D0 (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
AU3439393A (en) Medical grade adhesives and their preparation
AU4480693A (en) Method for the safe administration of fatty acid
AU1447892A (en) Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same
AU5757686A (en) Optical therapeutic and surgical system
AU4480793A (en) Method for the safe administration of fatty acid

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired